{
  "channel": "\ud83c\udf52-select-news",
  "messages": [
    {
      "id": "1139240765260836936-1451182298102759425",
      "content": "PYXS  < $4  - Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma - Link  ~  :flag_us:  |  Float: 48.1 M  |  IO: 38.03%  |  MC: 210 M",
      "timestamp": "2025-12-18T12:00:21.531Z",
      "author": "PR - Spike"
    }
  ],
  "sent_at": "2025-12-18T12:00:22.113Z"
}